29.04.2022 - MELVILLE, N.Y., April 29, 2022 (GLOBE NEWSWIRE) - BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage biopharmaceutical company focused on stem cell-based therapies, today announced that it is . Seite 1